Tao Fu, Attovia Therapeutics CEO
June 20, 2023 07:30 AM EDT
Financing
Startups

Fra­zier and Ala­mar Bio­sciences cre­ate im­mune and can­cer biotech At­tovia with $60M in fund­ing

Kyle LaHucik

Senior Reporter

Fra­zier Life Sci­ences is team­ing up with ven­Bio and Il­lu­mi­na Ven­tures to cre­ate a new im­mune-me­di­at­ed and can­cer-fo­cused biotech spun out of the pre­ci­sion pro­teomics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times